This study tells us that merely getting the spike via vaccine induces some of the same antibodies people will naturally create, but that no vaccinated person can create antibodies against any other place in the virus, yet, good spike antibodies can be of solid help for all, unless the spike changed too much.
One with mild fauciflu and no jab: N protein >2500 (2500 is ceiling), Total AB index 226
One with bad (home treated) fauciflu + Moderna jabs: N protein 1407, Total AB index 10.9
These tests are 10 months after fauciflu. The one with nojab had an N Protein of 2500 3 months ago.
I'm no MD but it looks to me like the nojab has better natural immunity with no decrease (actually an increase) over 3 months.
Comments?
I see you are correct. There was a post on FR discussing antibody production in Covid-19 survivors. It was found that multiple different antibodies were produced during infection targeting different epitopes.
According to the article antibodies from vaccinated and infected individuals are directed against the spike protein. Therefore infection should be as good as vaccination, at least.
However an infected and recovered individual produces more types of antibodies than does a vaccinated person (e.g. against the nucleoprotein). Would it not make sense that if the spike protein mutates a previously infected person would still have other antibodies to fight the virus?
Here is an article about this if you want to read it:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8095229/
We have only one defense against the Delta Variant that I have been able to find. It is not a vaccine. It is the potential use of a nebulizer with AR-712 cocktail by Aridis. But the last time I tried I could not buy a nebulizer without doctor Rx. Fortunately I have a nebulizer. There may be other preventive measures emerging but this is the only one I have been able to find. The Delta Variant hides from the immune system that is why it is spreading.
https://news.yahoo.com/data-suggests-pfizer-modernas-vaccines-090012364.html
“...the vaccines’ effectiveness against infection dropped sharply in July, when the Delta variant’s prevalence in Minnesota had risen to over 70%.
Moderna was 76% effective against infection, and Pfizer was only 42% effective.”
*